HSDT

SEC source: 0001209191-19-060771 · doc4.xml · derivative · entry 1

STRAW EDWARD M · CIK 0001075380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 20,000 shares

Expires 2019-12-08

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 8, 2014 resulting in the deemed cancellation of the December 8, 2014 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060778 · doc4.xml · derivative · entry 2

GRIFFIN THOMAS E · CIK 0001625114 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class A Common Stock · 20,000 shares

Expires 2026-08-08

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on August 8, 2016 resulting in the deemed cancellation of the August 8, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060778 · doc4.xml · derivative · entry 1

GRIFFIN THOMAS E · CIK 0001625114 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 20,000 shares

Expires 2020-08-08

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on August 8, 2016 resulting in the deemed cancellation of the August 8, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060776 · doc4.xml · derivative · entry 2

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Class A Common Stock · 300,000 shares

Expires 2026-07-13

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060776 · doc4.xml · derivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 300,000 shares

Expires 2020-07-13

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060774 · doc4.xml · derivative · entry 4

Peng Huaizheng · CIK 0001662081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2026-07-13

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060774 · doc4.xml · derivative · entry 3

Peng Huaizheng · CIK 0001662081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 15,000 shares

Expires 2020-07-13

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060774 · doc4.xml · derivative · entry 2

Peng Huaizheng · CIK 0001662081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Class A Common Stock · 10,000 shares

Expires 2025-12-31

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 31, 2015 resulting in the deemed cancellation of the December 31, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060774 · doc4.xml · derivative · entry 1

Peng Huaizheng · CIK 0001662081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 10,000 shares

Expires 2020-12-31

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 31, 2015 resulting in the deemed cancellation of the December 31, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060773 · doc4.xml · derivative · entry 6

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Class A Common Stock · 120,000 shares

Expires 2026-07-13

F4 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060773 · doc4.xml · derivative · entry 5

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 120,000 shares

Expires 2020-07-13

F4 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060773 · doc4.xml · derivative · entry 4

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Class A Common Stock · 150,000 shares

Expires 2025-10-21

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on October 21, 2015 resulting in the deemed cancellation of the October 21, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060773 · doc4.xml · derivative · entry 3

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 150,000 shares

Expires 2020-10-21

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on October 21, 2015 resulting in the deemed cancellation of the October 21, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060773 · doc4.xml · derivative · entry 2

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class A Common Stock · 20,000 shares

Expires 2025-03-16

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on March 16, 2015 resulting in the deemed cancellation of the March 16, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060773 · doc4.xml · derivative · entry 1

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 20,000 shares

Expires 2020-03-16

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on March 16, 2015 resulting in the deemed cancellation of the March 16, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060775 · doc4.xml · derivative · entry 4

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class A Common Stock · 20,000 shares

Expires 2026-07-13

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060775 · doc4.xml · derivative · entry 3

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 20,000 shares

Expires 2020-07-13

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060775 · doc4.xml · derivative · entry 2

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Class A Common Stock · 10,000 shares

Expires 2025-12-31

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 31, 2015 resulting in the deemed cancellation of the December 31, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060775 · doc4.xml · derivative · entry 1

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 10,000 shares

Expires 2020-12-31

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 31, 2015 resulting in the deemed cancellation of the December 31, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 4

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Class A Common Stock · 120,000 shares

Expires 2026-07-13

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 3

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 120,000 shares

Expires 2020-07-13

F3 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 2

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Class A Common Stock · 80,000 shares

Expires 2024-12-08

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 8, 2014 resulting in the deemed cancellation of the December 8, 2014 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-060770 · doc4.xml · derivative · entry 1

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 80,000 shares

Expires 2019-12-08

F1 · kind: These two reported transactions involved an amendment of an outstanding option originally granted on December 8, 2014 resulting in the deemed cancellation of the December 8, 2014 option and the grant of a replacement option with the same terms other than the expiration date.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-19-058420 · doc4.xml · nonDerivative · entry 3

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 349,099

F1 · kind: Acquired from the Issuer on November 27, 2019 pursuant to a Subscription Agreement dated November 22, 2019. The Subscription Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors.

F2 · balance_after: Reflects a 5-for-1 reverse stock split of the Issuer's Class A Common Stock effected on January 22, 2018, which was not reflected in the Reporting Person's prior filings.

F5 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-19-058420 · doc4.xml · nonDerivative · entry 2

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 132,004

F1 · kind: Acquired from the Issuer on November 27, 2019 pursuant to a Subscription Agreement dated November 22, 2019. The Subscription Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors.

F2 · balance_after: Reflects a 5-for-1 reverse stock split of the Issuer's Class A Common Stock effected on January 22, 2018, which was not reflected in the Reporting Person's prior filings.

F4 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-19-058420 · doc4.xml · nonDerivative · entry 1

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 620,435

F1 · kind: Acquired from the Issuer on November 27, 2019 pursuant to a Subscription Agreement dated November 22, 2019. The Subscription Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors.

F2 · balance_after: Reflects a 5-for-1 reverse stock split of the Issuer's Class A Common Stock effected on January 22, 2018, which was not reflected in the Reporting Person's prior filings.

F3 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-19-054778 · doc4.xml · derivative · entry 1

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-09-23

F1 · date: Represents a stock option to purchase 150,000 shares of the Issuer's common stock (the "Option") granted pursuant to the Issuer's 2018 Omnibus Incentive Plan on September 23, 2019, which shares originally were scheduled to vest upon the achievement of a performance-based vesting milestone. Pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder, a grant of stock options subject to performance-based vesting conditions is not reportable on Form 4 until such vesting conditions are satisfied.

F2 · date: Effective October 29, 2019, the Compensation Committee of the Issuer amended the terms of the Option to replace the performance-based vesting schedule with a time-based vesting schedule, whereby 25% of the shares underlying the Option shall vest on September 30, 2020, and the remainder of the shares underlying the Option shall vest in equal monthly installments over the following 48 months, subject to the Reporting Person's continued service through each such date. Upon the establishment of the time-based vesting schedule, the award became reportable on Form 4.

F1 · derivative.exercise_date: Represents a stock option to purchase 150,000 shares of the Issuer's common stock (the "Option") granted pursuant to the Issuer's 2018 Omnibus Incentive Plan on September 23, 2019, which shares originally were scheduled to vest upon the achievement of a performance-based vesting milestone. Pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder, a grant of stock options subject to performance-based vesting conditions is not reportable on Form 4 until such vesting conditions are satisfied.

F2 · derivative.exercise_date: Effective October 29, 2019, the Compensation Committee of the Issuer amended the terms of the Option to replace the performance-based vesting schedule with a time-based vesting schedule, whereby 25% of the shares underlying the Option shall vest on September 30, 2020, and the remainder of the shares underlying the Option shall vest in equal monthly installments over the following 48 months, subject to the Reporting Person's continued service through each such date. Upon the establishment of the time-based vesting schedule, the award became reportable on Form 4.

SEC source: 0001209191-19-025273 · doc4.xml · derivative · entry 3

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,018 shares

Expires 2019-04-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00=CAD$1.3387 on April 5, 2019. The exercise price of the Warrant was CAD $7.50.

SEC source: 0001209191-19-025273 · doc4.xml · nonDerivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-022115 · doc4.xml · derivative · entry 1

STRAW EDWARD M · CIK 0001075380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,218

Underlying: Class A Common Stock · 16,218 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022119 · doc4.xml · derivative · entry 1

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of forty-eight (48) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022118 · doc4.xml · derivative · entry 1

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of forty-eight (48) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022117 · doc4.xml · derivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Class A Common Stock · 160,000 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of forty-eight (48) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022116 · doc4.xml · derivative · entry 1

Tyler Mitch E · CIK 0001638208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,733

Underlying: Class A Common Stock · 14,733 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022114 · doc4.xml · derivative · entry 1

Peng Huaizheng · CIK 0001662081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,525

Underlying: Class A Common Stock · 15,525 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022113 · doc4.xml · derivative · entry 1

GRIFFIN THOMAS E · CIK 0001625114 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,891

Underlying: Class A Common Stock · 18,891 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022112 · doc4.xml · derivative · entry 1

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,901

Underlying: Class A Common Stock · 17,901 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-19-022111 · doc4.xml · derivative · entry 1

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,990

Underlying: Class A Common Stock · 18,990 shares

Expires 2029-03-28

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-042409 · doc4.xml · derivative · entry 1

Laux Jennifer · CIK 0001746180 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Class A Common Stock · 150,000 shares

Expires 2028-07-09

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest over four years, with 25% of the shares vesting on July 9, 2019 and the remaining shares vesting monthly thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 9

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 792,703

F3 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 8

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 326,555

F2 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 7

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,491,311

F1 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 6

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 791,886

F3 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 5

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 326,251

F2 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 4

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,489,932

F1 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 3

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 791,069

F3 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 2

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 325,947

F2 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-039751 · doc4.xml · nonDerivative · entry 1

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,488,553

F1 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-18-031244 · doc4.xml · derivative · entry 1

STRAW EDWARD M · CIK 0001075380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Class A Common Stock · 12,500 shares

Expires 2028-05-15

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-031243 · doc4.xml · derivative · entry 1

Peng Huaizheng · CIK 0001662081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Class A Common Stock · 12,500 shares

Expires 2028-05-15

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.